Basic fibroblast growth factor and epidermal growth factor downmodulate the growth of hematopoietic cells in long‐term stromal cultures
- 1 November 1995
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 165 (2) , 386-397
- https://doi.org/10.1002/jcp.1041650220
Abstract
The bone marrow microenvironment consists of stromal cells and extracellular matrix components which act in concert to regulate the growth and differentiation of hematopoietic stem cells. There is little understanding of the mechanisms which modulate the regulatory role of stromal cells. This study examined the hypothesis that mesenchymal growth factors such as basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF) modulate stromal cell activities and thereby influence the course of hematopoiesis. Both bFGF and EGF were potent mitogens for marrow stroma. However, both factors proved to be inhibitory to hematopoiesis in primary log-term marrow cultures. Inhibition was also observed when hematopoietic cells and bFGF or EGF were added to subconfluent irradiated stromal layers, demonstrating that the decline of hematopoiesis was not due to overgrowth of the stromal layer. Loss of hematopoietic support in bFGF and EGF was dose-dependent. Removal of bFGF and EGF permitted stromal layers to regain their normal capacity to support hematopoiesis. In stroma-free long-term cultures, neither factor affected CFU-GM expansion. Basic FGF slightly enhanced granulocyte-macrophage colony forming unit (CFU-GM) cloning efficiency in short-term agarose culture. Basic FGF did not reduce the levels of interleukin-6 (IL-6), GM-CSF, or G-CSF released by steady state or IL-1-stimulated stroma. Similarly, the constitutive levels of steel factor (SF) mRNA and protein were not affected by bFGF. Basic FGF did not alter the level of TGF-β1 in stromal cultures. We conclude that bFGF and EGF can act as indirect negative modulators of hematopoietic growth in stromal cultures. The actual mediators of regulation, whether bound or soluble, remain to be identified.Keywords
This publication has 46 references indexed in Scilit:
- Platelet-derived growth factor is a potent biologic response modifier of T cells.The Journal of Experimental Medicine, 1991
- Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan.The Journal of cell biology, 1991
- Primary structure and functional expression of rat and human stem cell factor DNAsCell, 1990
- "Pure" Human Hematopoietic Progenitors: Permissive Action of Basic Fibroblast Growth FactorScience, 1990
- Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.The Journal of cell biology, 1990
- Recent developments in the cell biology of basic fibroblast growth factor.The Journal of cell biology, 1989
- THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINSAnnual Review of Biochemistry, 1989
- Effects of platelet derived growth factor, epidermal growth factor and transforming growth factor-β on the growth of human marrow fibroblastsBritish Journal of Haematology, 1988
- Platelet‐derived growth factor stimulates growth of highly enriched multipotent haemopoietic progenitorsBritish Journal of Haematology, 1986
- A Method for Isolation of Intact, Translationally Active Ribonucleic AcidDNA, 1983